Zacks Research Issues Positive Forecast for ACHC Earnings

Key Points

• Zacks Research raised its Q4 2026 EPS estimate for Acadia Healthcare (NASDAQ: ACHC) to $0.25 from $0.19, signaling a more optimistic near-term earnings outlook. The firm still rates the stock Hold.
• Zacks also improved longer-term projections, lifting FY2027 EPS to $1.63 and FY2028 EPS to $1.76, which suggests confidence in Acadia’s earnings growth beyond this year.
• Acadia recently beat Q1 earnings and revenue expectations, reporting $0.37 EPS on $828.8 million in revenue, while guiding Q2 2026 EPS to $0.30-$0.40. The stock was down about 1.3% in Friday trading despite the upbeat forecast changes.

Acadia Healthcare Company, Inc. (NASDAQ:ACHC - Free Report) - Zacks Research upped their Q4 2026 EPS estimates for shares of Acadia Healthcare in a research note issued on Wednesday, May 13th. Zacks Research analyst Team now expects that the company will earn $0.25 per share for the quarter, up from their prior estimate of $0.19. Zacks Research has a "Hold" rating on the stock. The consensus estimate for Acadia Healthcare's current full-year earnings is $1.49 per share. Zacks Research also issued estimates for Acadia Healthcare's Q1 2027 earnings at $0.26 EPS, Q2 2027 earnings at $0.45 EPS, Q3 2027 earnings at $0.54 EPS, Q4 2027 earnings at $0.38 EPS and FY2027 earnings at $1.63 EPS.

ACHC has been the subject of several other reports. Jefferies Financial Group reissued a "hold" rating and set a $24.50 price objective on shares of Acadia Healthcare in a research note on Monday, April 20th. Guggenheim upped their target price on Acadia Healthcare from $26.00 to $31.00 and gave the company a "buy" rating in a report on Monday, May 4th. Weiss Ratings reiterated a "sell (d)" rating on shares of Acadia Healthcare in a research report on Wednesday, January 21st. Leerink Partners lifted their price target on Acadia Healthcare from $14.00 to $22.00 and gave the stock a "market perform" rating in a research note on Thursday, February 26th. Finally, UBS Group upped their price objective on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a "buy" rating in a research note on Friday, April 17th. One analyst has rated the stock with a Strong Buy rating, six have given a Buy rating, seven have given a Hold rating and two have given a Sell rating to the stock. Based on data from MarketBeat, Acadia Healthcare currently has an average rating of "Hold" and an average target price of $26.04.

Acadia Healthcare Trading Down 1.3%

Acadia Healthcare stock opened at $26.80 on Friday. The firm has a market cap of $2.46 billion, a price-to-earnings ratio of -2.19, a price-to-earnings-growth ratio of 9.13 and a beta of 0.73. Acadia Healthcare has a 1 year low of $11.43 and a 1 year high of $30.20. The firm's 50 day moving average price is $25.25 and its two-hundred day moving average price is $19.22. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71.

Acadia Healthcare (NASDAQ:ACHC - Get Free Report) last released its earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, topping analysts' consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million for the quarter, compared to the consensus estimate of $823.51 million. During the same period in the previous year, the firm earned $0.40 EPS. The business's revenue for the quarter was up 7.6% on a year-over-year basis. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of ACHC. Atika Capital Management LLC purchased a new stake in Acadia Healthcare in the 1st quarter worth about $2,868,000. Sei Investments Co. increased its holdings in shares of Acadia Healthcare by 39.0% in the 1st quarter. Sei Investments Co. now owns 316,398 shares of the company's stock valued at $7,401,000 after purchasing an additional 88,841 shares during the period. Lido Advisors LLC acquired a new position in shares of Acadia Healthcare in the 1st quarter valued at about $474,000. Militia Capital Management LLC purchased a new stake in shares of Acadia Healthcare in the first quarter worth approximately $2,842,000. Finally, First Trust Advisors LP boosted its holdings in shares of Acadia Healthcare by 73.0% during the first quarter. First Trust Advisors LP now owns 1,689,442 shares of the company's stock worth $39,516,000 after purchasing an additional 712,852 shares during the period.

More Acadia Healthcare News

Here are the key news stories impacting Acadia Healthcare this week:

• Positive Sentiment: Zacks Research raised its price target on Acadia Healthcare NASDAQ: ACHC to $28.82, implying improved valuation expectations. Article Title
• Positive Sentiment: Zacks lifted longer-term EPS forecasts, including FY2027 to $1.63 from $1.55 and FY2028 to $1.76 from $1.67, reflecting a stronger earnings outlook.
• Positive Sentiment: Nearer-term estimates were also increased for Q1 2027 to $0.26, Q2 2027 to $0.45, Q3 2027 to $0.54, and Q4 2027 to $0.38.
• Neutral Sentiment: Zacks continues to rate the stock Hold, so the revisions are constructive but not a full bullish call.
• Negative Sentiment: Some near-term estimates were cut, including FY2026 to $1.46 from $1.48, Q2 2026 to $0.35 from $0.49, and Q3 2026 to $0.49 from $0.52, which could weigh on sentiment.

About Acadia Healthcare

Acadia Healthcare Company, Inc NASDAQ: ACHC is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.